News

Options Trading Insights and Market Overview of Coherent

Options Trading Insights and Market Overview of Coherent

Understanding Coherent Options Activity

In recent times, Coherent has witnessed a notable shift in the options market, indicating bullish sentiment among traders. Our thorough analysis of trading activities reveals intriguing patterns regarding the stock's potential trajectory.

Within the options data analyzed for Coherent (COHR), we noted a balanced view among traders, with approximately 45% showing bullish tendencies and another 45% demonstrating bearish inclinations. This showcases a market segment poised for significant movements. Among the recorded transactions, three were identified as puts, amounting to $138,401, while calls accounted for eight trades, totaling a value of $349,637.

Price Range Predictions for Coherent

Delving deeper into the trends, we observe that the options activity suggests a target price fluctuation between $50.0 and $165.0 for Coherent over the past three months. Whales have been particularly active, underscoring their strategic interest in this price segment.

Insights on Volume and Open Interest

Examining the interplay of volume and open interest enables us to gain critical insights into Coherent's stock dynamics. This analytics approach is crucial for assessing liquidity and gauging trader interest at various strike prices. Below, we highlight key findings regarding the trends observed in the volume and open interest for both calls and puts over the last month.

Analysis of Recent Options Activity

Over the last month, specific options trading activities have caught our attention, and we present a snapshot of the pivotal trades:

Significant Options Trades Identified

Here’s a summary of the recent notable trades:

Symbol: COHR
Trade Type: SWEEP | PUT/CALL: CALL | Sentiment: BEARISH | Exp. Date: 01/15/27 | Price: $5.44 | Total Trade Price: $89.5K | Open Interest: 165

Symbol: COHR
Trade Type: SWEEP | PUT/CALL: PUT | Sentiment: BEARISH | Exp. Date: 07/18/25 | Price: $6.5 | Total Trade Price: $71.5K | Open Interest: 234

Symbol: COHR
Trade Type: TRADE | PUT/CALL: CALL | Sentiment: BEARISH | Exp. Date: 04/17/25 | Price: $2.48 | Total Trade Price: $61.7K | Open Interest: 181

Symbol: COHR
Trade Type: SWEEP | PUT/CALL: CALL | Sentiment: NEUTRAL | Exp. Date: 04/04/25 | Price: $2.3 | Total Trade Price: $46.0K | Open Interest: 1

Symbol: COHR
Trade Type: TRADE | PUT/CALL: CALL | Sentiment: BULLISH | Exp. Date: 01/16/26 | Price: $28.0 | Total Trade Price: $42.0K | Open Interest: 86

Overview of Coherent Corp

Coherent Corp is a robust player in the fields of materials, networking, and lasers, working as a vertically integrated manufacturer. The firm specializes in developing, manufacturing, and marketing engineered materials alongside optoelectronic components and lasers, catering to industrial, communications, electronics, and instrumentation sectors. Coherent operates through three segments: Networking, Materials, and Lasers, earning the majority of its revenue from the Networking segment.

In addition to evaluating market sentiments from options trading, it’s essential to consider Coherent’s current market status for a holistic view.

Latest Market Status for Coherent

  • Current trading volume sits at 3,052,625, with shares of COHR reflecting a decline of 8.37%, priced at $68.89.
  • The Relative Strength Index (RSI) indicates that the stock is currently maintaining a neutral position between overbought and oversold.
  • Upcoming earnings announcements are projected within the next 63 days, which might influence price dynamics.

Analyst Outlook on Coherent

Recent insights shared by five industry analysts have provided an average target price for the stock at $111.0, showcasing diverse perspectives on its potential future performance.

Furthermore, analyst ratings suggest the following:

  • An analyst from Rosenblatt has maintained a Neutral rating, adjusting the target price to $115.
  • B of A Securities continues with a Buy rating, targeting a price of $125.
  • Northland Capital Markets has rated Coherent as Market Perform, with a target of $80.
  • Raymond James retains an Outperform rating, targeting $110.
  • Needham remains with a Buy stance, maintaining a price target of $125.

While options trading can introduce complexities and risk compared to stock trading, it also holds the potential for enhanced profits. Serious traders often navigate this risk by staying informed, managing trades diligently, and keeping a close eye on market indicators.

Stay alert to the ongoing options trading activities impacting Coherent as they unfold.

Frequently Asked Questions

What recent trends are evident in Coherent's options activity?

Recent options activity shows a mix of bullish and bearish sentiments, with notable trades highlighting interest in specific price ranges.

How does volume and open interest impact trading strategies?

Volume and open interest indicate trader interest and liquidity, crucial for making informed trading decisions regarding options.

What are the target prices set by analysts for Coherent?

Analysts have provided target prices ranging from $80 to $125, reflecting varied expectations for Coherent's future performance.

What insights do analysts provide about Coherent's market status?

Analysts maintain a mixed outlook for Coherent with varied ratings reflecting their confidence in its market positioning and future earnings prospects.

Why is options trading considered riskier than stock trading?

Options involve leveraged positions and varying expiration dates, introducing additional complexities and risks compared to trading stocks directly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 392

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 253

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 204

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 200

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading

Top 5 Most Recently Viewed Articles

AngioDynamics' NanoKnife® System Receives FDA Clearance

Updated Category News Views 191

Introduction to AngioDynamics' Innovation AngioDynamics, Inc. (NASDAQ: ANGO), a forward-thinking medical technology firm, has made significant strides in restoring healthy blood flow and enhancing cancer treatment options. Recently, the company announced its accomplishment in receiving FDA 510(k) clearance for its advanced NanoKnife System, specifically designed for...

Continue Reading
Analyst Predicts iPhone Dominance in Apple's Future Revenues

Updated Category News Views 197

Apple's Revenue Outlook and iPhone Influence A recent analysis by Needham paints a promising picture for Apple Inc (NASDAQ: AAPL) as the company prepares for fiscal year 2025. Analyst Laura Martin affirmed a buy rating for Apple, setting an impressive price target of $260. This forecast is based on a well-crafted Discounted Cash Flow (DCF) model, which includes a cash tax...

Continue Reading
Sitetracker's Record Growth and Vision for Future Success

Updated Category News Views 398

Remarkable Achievements in 2024 for Sitetracker Sitetracker has reached significant milestones marking the close of its fiscal year with outstanding growth and exciting plans for the upcoming year. As a leader in the field of asset lifecycle management, they have positioned themselves strongly in markets worldwide, focusing on providing tools for various critical...

Continue Reading
Olympus Showcases Innovative ENT Solutions at Major Meetings

Updated Category News Views 176

Olympus Highlights Cutting-Edge ENT Solutions Olympus Corporation of the Americas, a leading medical technology company committed to enhancing health and safety, will unveil its extensive ENT portfolio at upcoming annual physician meetings. Attendees will have the opportunity to see how Olympus integrates hybrid endoscopy with advanced imaging and content management...

Continue Reading
Exciting Launch of Tech Mahindra Chess League Season 3

Updated Category News Views 101

Tech Mahindra Global Chess League Season 3 Launches with Excitement The Global Chess League (GCL) has officially begun its Season 3, and excitement fills the air as six teams are set to compete in 34 matches for the coveted championship trophy. The league kicked off at Mumbai's Royal Opera House, a perfect venue for this grand event. Spectacular Opening Ceremony in Mumbai...

Continue Reading